CHANGE IN RATINGS
Allstate (ALL) downgraded at J.P. Morgan to Underweight from Neutral. Price target cut to $25 from $38. Boston Scientific (BSX) upgraded at Weisel from Underweight to Overweight. $11 price target. Boston Scientific numbers lowered at Morgan Stanley. Estimates cut through 2009. Overweight rating. Boston Scientific upgraded at Wachovia to Outperform. C.H. Robinson (CHRW) upgraded at Goldman Sachs to Neutral from Sell. Price target raised to $49 from $41. Charles River (CRL) downgraded at UBS from Neutral to Sell. $22 price target. Fairchild Semiconductor (FCS) downgraded at Barclays to Equal-weight from Overweight and price target reduced to $5 from $7. Starwood Hotels (HOT) downgraded at Oppenheimer from Outperform to Perform. $15 price target. International Paper (IP) downgraded at Barclays to Underweight from Equalweight and price target reduced to $7 from $10. Juniper Networks (JNPR) downgraded at Piper Jaffray to Neutral from Buy. Price target cut to $16 from $21. KLA-Tencor (KLAC) upgraded at Merrill/BofA from Neutral to Buy. $24 price target. Lululemon Athletica (LULU) upgraded at Goldman to Neutral from Sell. Price target at $6.50. Nucor (NUE) downgraded at Goldman Sachs to Neutral from Buy. Price target at $44. PerkinElmer (PKI) downgraded at Weisel from Overweight to Market-weight. $14 price target. Teradyne (TER) upgraded at Goldman Sachs to Buy from Neutral. Price target raised to $6 from $3. Terra Industries (TRA) upgraded at Goldman Sachs to Buy from Neutral. T. Rowe Price (TROW) downgraded at JP Morgan from Neutral to Underweight. $28 price target.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet